Gossamer Bio, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+47.1% +$4M
$14M
R&D↑+35.5% +$13M
$49M
D&A↓-94.4% -$102K
$6K
Operating Income↓-44.8% -$15M
$-49M
EBITDA↓-94.4% -$102K
$6K
Interest Expense↑+0.5% +$13K
$3M
Interest Income
$447K
Other Income/Expense↓-31.1% -$1M
$3M
Pretax Income↓-51.0% -$16M
$-48M
Tax Provision↑+100.0% +$1M
$0
Net Income↓-56.5% -$17M
$-48M
Operating Margin↓-11.6pts
-369.4%
Net Margin↓-37.8pts
-362.7%
Effective Tax Rate↓-3.5pts
0.0%
ETR (Continuing Operations)↑+1.6pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
0.0%
ETR Foreign Differential (pp)↑+1.3pts
-2.5%
Operating Lease Cost↓-68.5% -$779K
$358K
Revenue YoY Variation
47.1%
Income YoY Variation↓-61.0pts
-44.8%
Revenue QoQ Variation↑+4.9pts
3.8%
Income QoQ Variation↑+138.4pts
-26.7%